Management of Hereditary Hypofibrinogenemia During Pregnancy: A Scoping Review Towards Personalized Obstetric Care
Journal of Clinical Medicine · 16.06.2026 · 15 (12) · 4666
DOI: 10.3390/jcm15124666 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.06.2026. Verfasst von Grigorios Karampas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Obstetrics and Gynaecology, "Aretaieio" University Hospital, Medical School, National and Kapodistrian University of Athens, 115…. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hereditary fibrinogen disorders comprise a rare and heterogeneous group of conditions characterized by highly variable clinical phenotypes, ranging from entirely asymptomatic to severe hemorrhage or paradoxical thrombosis. Within this spectrum, hereditary hypofibrinogenemia (HH) poses a significant obstetrical challenge due to the lack of evidence-based management guidelines during pregnancy.
Methods
A scoping review of the literature was conducted to identify reported cases of pregnancies with HH reaching the third trimester. PubMed, Scopus, and Cochrane Library were searched through April 2026 for eligible studies reporting maternal and neonatal outcomes, fibrinogen replacement therapy during pregnancy, and peri- and postpartum management. A complementary LeapSpace search was also performed. Data were extracted using a structured form and owing to the heterogeneity and descriptive nature of the available evidence, results were synthesized narratively.
Results
Out of 202 unique records identified, a total of 13 studies, comprising 33 pregnancies, were included. All evidence arose from case reports and small case series, with substantial variability in patient characteristics and clinical management. Successful outcomes are associated with early diagnosis, careful assessment of medical and obstetrical history, and close multidisciplinary surveillance. Maintaining fibrinogen levels above 50–100 mg/dL during pregnancy and ≥150 mg/dL peripartum appeared beneficial. The use of global coagulation assessment tools such as rotational thromboelastometry (ROTEM®), particularly the FIBTEM® assay, may support individualized management beyond fibrinogen levels alone; however, up to date it has been incorporated in the management of a single pregnancy.
Conclusions
Management of pregnancy in women with HH should be individualized and multidisciplinary, with tailored fibrinogen supplementation strategies to optimize maternal and neonatal outcomes. Small sample sizes and the heterogeneity of the reported results limit the certainty of these findings, requiring further research to establish subtype-specific recommendations and to define additional coagulation parameters that may improve perinatal care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Department of Obstetrics and Gynaecology, "Aretaieio" University Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
- Department of Midwifery, School of Health and Care Sciences, University of West Attica, 12243 Athens, Greece.
- Laboratory of Heamatology, Blood Transfusion Unit, "Aretaieio" University Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
- First Department of Anesthesiology, "Aretaieio" University Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
ORCID-Profile: Grigorios Karampas, Konstantinos Karkalemis, Anastasia Bagiasta, Dimitra Metallinou, Makarios Eleftheriades, Panagiotis Christopoulos
Zitieren
APA
Karampas, G., Karkalemis, K., Bagiasta, A., Metallinou, D., Tsarna, E., Lefaki, M., Staikou, C., Eleftheriades, M., Christopoulos, P., & Politou, M. (2026). Management of Hereditary Hypofibrinogenemia During Pregnancy: A Scoping Review Towards Personalized Obstetric Care. Journal of Clinical Medicine, 15(12), 4666. https://doi.org/10.3390/jcm15124666
Vancouver
Karampas G, Karkalemis K, Bagiasta A, Metallinou D, Tsarna E, Lefaki M, et al. Management of Hereditary Hypofibrinogenemia During Pregnancy: A Scoping Review Towards Personalized Obstetric Care. Journal of Clinical Medicine. 2026;15(12):4666. doi:10.3390/jcm15124666
BibTeX
@article{Karampas2026,
author = {Karampas, Grigorios and Karkalemis, Konstantinos and Bagiasta, Anastasia and Metallinou, Dimitra and Tsarna, Ermioni and Lefaki, Marikaiti and Staikou, Chryssoula and Eleftheriades, Makarios and Christopoulos, Panagiotis and Politou, Marianna},
title = {Management of Hereditary Hypofibrinogenemia During Pregnancy: A Scoping Review Towards Personalized Obstetric Care},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4666},
doi = {10.3390/jcm15124666}
}
EUVIMED